FDA requires lower doses for sleep medications
WASHINGTON -- The Food and Drug Administration is requiring makers of Ambien and similar sleeping pills to lower the dosage of their drugs, based on studies suggesting patients face a higher risk of injury due to morning drowsiness.
The agency says new research shows that the widely-used sleeping drugs remain in the blood at levels high enough to interfere with driving, which increases the risk of car accidents.
Regulators are ordering drug manufacturers to cut the dose of the medications in half for women, who process the drug more slowly. The FDA is also recommending that manufacturers use the lower doses for men, though it will not be mandatory.
The new doses apply to all insomnia treatments containing the drug zolpidem, which is sold under the brands Ambien, Edluar and Zolpimist.
drugs, DUI, prescription drug, FDA, driving, health
- Wounded police officer back in surgery
- Amber Alert canceled for child from Long Beach
- Officials investigating acid spill at Tesoro refinery
- Conn. shooter's dad: 'You can't get any more evil'
- Drought prompts officials to release water in Delta
- Tuolumne County man found guilty in I-580 shooting
- Petaluma foster home in danger of closing
- 6.9 earthquake rattles Northern California
- Man gets prison time in laser-pointer case
- Bill introduced to have utilities develop security plan
- Petaluma police searching for suspected drive-thru thief
- abcnews: 'The Bachelor' Finale Full Recap
- weather: Bay Area weather forecast for Tuesday
- roundup: Tesoro chemical spill; SOMA fire